Trialect

+ More Filters

Reset Filters

Specialty

Funding Organization

Funding Type

Eligible Country

Deadline

From

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Not Verified

Notice of Special Interest (NOSI): NIDDK National Research Service Award (NRSA) T32 Diversity Administrative Supplement

National Institutes of Health

In effort to promote a diverse research workforce in NIDDK fields of research, NIDDK is making available this opportunity for additional trainee research slots to eligible candidates on a T32 or TL1 when all regularly-awarded positions have been filled. NIDDK encourages individuals from diverse backgrounds, including but not limited to those from underrepresented racial and ethnic groups, individuals with disabilities, and individuals from disadvantaged backgrounds, to work with their institutions to submit an application for support. For more information, see NOT-OD-20-031 “Notice of NIH's Interest in Diversity.”

Please note that NIH does not use the race, ethnicity, or sex of prospective candidates in the application review process or funding decisions. Applicants are encouraged to consult with their General Counsel to ensure all applicable laws and regulations are being followed in the selection of candidates.

The NIDDK administratively funds supplemental slots designated specifically for a selected trainee - either predoctoral or postdoctoral - to an existing T32 or TL1 award. That position remains a part of the T32 or TL1 for as long as the named individual is a member of the training program. When the individual no longer receives support from the T32, the funds for the position are removed from the grant.

To ensure an appropriate training experience, only predoctoral slots are considered for programs that exclusively support predoctoral training; the same applies to postdoctoral slots. Programs supporting both predoctoral and postdoctoral training may apply for either.

Application Due Date(s) – Applications will be accepted on a rolling basis, beginning February 12 - May 12, 2025, February 12 -May 12, 2026, and February 12 - May 12, 2027

NOT-DK-24-038

Specialties

Curriculum Development

Medical - Basic Science

Medical - Translational

Medical

Medical - Clinical Science

Eligibility Requirements

Individuals supported under this program must meet the administrative requirements for any trainee supported by a T32 or TL1 award (e.g., citizenship/permanent residency requirements, payback obligation) and must meet all the requirements for prior training, experience, and commitment to research expected of any other trainee in the particular T32 or TL1 program wishing to support them.

Usually only one additional trainee slot (either predoctoral or postdoctoral) will be awarded to any T32/TL1. If a trainee has been appointed to a regular slot on a T32 or TL1 grant, a supplemental slot will not be considered for additional years for that trainee.

Sponsor Details

Sponsor Institute/Organizations: National Institutes of Health

Address: National Institutes of Health; 31 Center Drive; MSC 2220; Bethesda; MD 20892-2220; USA

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity